Hospital
Adirondack Medical Center
Adirondack Medical Center was paid $13.43M by Medicaid between Jan 2018 and Nov 2024, across 240 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 36% of everything it billed.
33Billing provider infoADIRONDACK MEDICAL CENTER
SARANAC LAKE, NY 12983
SARANAC LAKE, NY 12983
33aNPI1699709576assigned 07/10/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$13.43M
24GClaims277,686
24DCodes billed240
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#72 of 231
Median peer was paid$561K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,338 | $35K | |
| 2019 | 19,505 | $765K | |
| 2020 | 49,664 | $2.02M | |
| 2021 | 66,183 | $2.68M | |
| 2022 | 56,654 | $3.87M | |
| 2023 | 52,289 | $2.64M | |
| 2024incomplete | 32,053 | $1.42M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 36% | 36,430 | 30,342 | $4.85M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.6% | 7,311 | 6,714 | $1.15M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 8.6% | 11,865 | 3,881 | $1.15M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.9% | 4,522 | 4,143 | $657K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.2% | 1,678 | 1,471 | $430K |
| 80053 | Comprehensive metabolic panel | 3.2% | 13,118 | 11,659 | $425K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.5% | 4,603 | 3,911 | $331K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.1% | 1,520 | 1,442 | $277K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.8% | 395 | 393 | $238K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.6% | 4,407 | 3,836 | $209K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.5% | 1,574 | 1,472 | $205K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.4% | 7,851 | 6,668 | $189K |
228 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.3% | 662 | $179K |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 13,322 | $147K |
| 87581 | <1% | 1,613 | $131K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,226 | $120K |
| 97161 | <1% | 1,266 | $120K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 400 | $117K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 5,405 | $116K |
| D0120 | Dental checkup, returning patient | <1% | 3,149 | $111K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 4,558 | $109K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 885 | $105K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 581 | $91K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,874 | $86K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 117 | $82K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 849 | $79K |
| 90686 | <1% | 1,909 | $78K | |
| D1110 | Prophylaxis - adult | <1% | 1,358 | $74K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,193 | $72K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,404 | $65K |
| 36416 | <1% | 295 | $65K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,416 | $64K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,852 | $63K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,650 | $63K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,971 | $60K |
| 97597 | <1% | 209 | $54K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,753 | $49K |
| 76830 | Ultrasound, transvaginal | <1% | 487 | $46K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 223 | $45K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 17,048 | $40K |
| 80061 | Lipid panel | <1% | 4,412 | $38K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,440 | $37K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 429 | $35K |
| 86900 | <1% | 666 | $34K | |
| 87800 | <1% | 1,608 | $32K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,644 | $30K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,049 | $28K |
| 90715 | <1% | 726 | $26K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,415 | $24K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 70 | $20K |
| 73560 | <1% | 376 | $20K | |
| 90836 | <1% | 216 | $19K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 586 | $18K |
| 90648 | <1% | 433 | $18K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,586 | $17K |
| 84703 | <1% | 1,928 | $15K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 254 | $15K |
| 84439 | <1% | 2,074 | $14K | |
| 82607 | <1% | 1,681 | $13K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 921 | $13K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 319 | $12K |
| 73610 | <1% | 387 | $12K | |
| 97803 | <1% | 133 | $11K | |
| 73030 | <1% | 294 | $11K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,272 | $11K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 110 | $10K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 113 | $10K |
| 90670 | <1% | 465 | $10K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 611 | $10K |
| 82728 | <1% | 1,315 | $10K | |
| 97162 | <1% | 90 | $9K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 54 | $9K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 43 | $9K |
| 59025 | Fetal non-stress test | <1% | 43 | $9K |
| 73630 | <1% | 266 | $9K | |
| 90734 | <1% | 258 | $8K | |
| 90651 | <1% | 191 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,300 | $8K |
| 85610 | <1% | 2,282 | $8K | |
| D0274 | Bitewings - four radiographic images | <1% | 270 | $8K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 357 | $8K |
| 86901 | <1% | 665 | $7K | |
| 90685 | <1% | 284 | $7K | |
| 86769 | <1% | 218 | $7K | |
| G0378 | Hospital observation service, per hour | <1% | 34 | $7K |
| 84702 | <1% | 1,043 | $7K | |
| 81001 | <1% | 6,012 | $7K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 124 | $7K |
| 82746 | <1% | 1,092 | $6K | |
| 86141 | <1% | 1,264 | $6K | |
| 99441 | <1% | 55 | $5K | |
| 86803 | <1% | 649 | $5K | |
| Q2036 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | <1% | 176 | $5K |
| 83655 | <1% | 423 | $5K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,692 | $5K |
| 87070 | <1% | 1,011 | $4K | |
| 90723 | <1% | 247 | $4K | |
| 83735 | <1% | 3,000 | $4K | |
| 0071A | <1% | 102 | $4K | |
| 73564 | <1% | 71 | $4K | |
| 97010 | <1% | 207 | $4K | |
| 99443 | <1% | 45 | $4K | |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 99 | $4K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 56 | $4K |
| 0002A | <1% | 93 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,613 | $4K |
| 87809 | <1% | 1,612 | $4K | |
| 83540 | <1% | 1,257 | $3K | |
| 0072A | <1% | 81 | $3K | |
| 87807 | <1% | 1,612 | $3K | |
| 0001A | <1% | 85 | $3K | |
| 83550 | <1% | 1,225 | $3K | |
| 80076 | <1% | 293 | $3K | |
| 81025 | <1% | 106 | $3K | |
| 71045 | Radiologic examination, chest; single view | <1% | 765 | $3K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 24 | $3K |
| 0004A | <1% | 69 | $3K | |
| 90633 | <1% | 53 | $3K | |
| 83880 | <1% | 98 | $2K | |
| 85730 | <1% | 1,451 | $2K | |
| 99442 | <1% | 27 | $2K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,315 | $2K |
| 90700 | <1% | 15 | $2K | |
| 87522 | Neg quan hep c or qual rna | <1% | 36 | $2K |
| 87340 | <1% | 245 | $2K | |
| 84153 | <1% | 131 | $2K | |
| 73562 | <1% | 70 | $2K | |
| 74018 | <1% | 47 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,899 | $2K |
| 76641 | <1% | 15 | $2K | |
| 87186 | <1% | 635 | $2K | |
| 80164 | <1% | 147 | $2K | |
| 93971 | <1% | 25 | $1K | |
| 93923 | <1% | 25 | $1K | |
| 86592 | <1% | 391 | $1K | |
| 85651 | <1% | 1,282 | $1K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 14 | $1K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 12 | $1K |
| 87210 | <1% | 540 | $1K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 3,116 | $1K |
| 86885 | <1% | 72 | $1K | |
| 87081 | <1% | 733 | $1K | |
| 90680 | <1% | 64 | $1K | |
| 83605 | <1% | 1,848 | $1K | |
| 83690 | <1% | 1,957 | $1K | |
| 84425 | <1% | 307 | $934.29 | |
| 84484 | <1% | 1,266 | $933.26 | |
| 90710 | <1% | 16 | $885.60 | |
| D0140 | Limited oral evaluation - problem focused | <1% | 21 | $851.43 |
| 97802 | <1% | 15 | $790.03 | |
| 73110 | <1% | 28 | $766.53 | |
| 72110 | <1% | 24 | $707.76 | |
| 73590 | <1% | 13 | $700.56 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 901 | $676.68 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,894 | $646.15 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 889 | $598.54 |
| 73130 | <1% | 27 | $591.51 | |
| 84550 | <1% | 311 | $569.39 | |
| 85018 | <1% | 30 | $536.05 | |
| 87205 | <1% | 318 | $533.15 | |
| 0012A | <1% | 13 | $493.23 | |
| D1120 | Dental cleaning, child | <1% | 12 | $473.00 |
| 90461 | <1% | 1,240 | $472.03 | |
| 84590 | <1% | 250 | $471.33 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 109 | $460.00 |
| 91320 | <1% | 16 | $368.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 32 | $360.00 |
| 82248 | <1% | 109 | $333.05 | |
| D0210 | Intraoral - complete series of radiographic images | <1% | 12 | $313.96 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 12 | $304.11 |
| 0124A | <1% | 27 | $297.85 | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,740 | $294.48 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 198 | $290.51 |
| 81002 | <1% | 243 | $286.75 | |
| 82962 | <1% | 330 | $259.35 | |
| 0011A | <1% | 19 | $251.37 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,879 | $250.46 |
| 90713 | <1% | 14 | $249.90 | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 15 | $210.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,651 | $208.69 |
| 86618 | <1% | 13 | $201.54 | |
| 73140 | <1% | 14 | $199.16 | |
| 87077 | <1% | 69 | $193.92 | |
| 84460 | <1% | 60 | $188.54 | |
| 81003 | <1% | 231 | $169.08 | |
| 0100U | <1% | 13 | $162.80 | |
| 90480 | <1% | 74 | $160.00 | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 12 | $157.92 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,413 | $156.74 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,797 | $137.36 |
| 80305 | <1% | 672 | $131.42 | |
| 87040 | <1% | 58 | $125.11 | |
| 85379 | <1% | 165 | $123.45 | |
| 84481 | <1% | 16 | $117.00 | |
| 82150 | <1% | 106 | $100.16 | |
| 73565 | <1% | 12 | $87.57 | |
| 80354 | <1% | 29 | $76.91 | |
| 86580 | <1% | 14 | $75.91 | |
| 80361 | <1% | 28 | $70.60 | |
| 80367 | <1% | 28 | $65.55 | |
| 80353 | <1% | 28 | $65.55 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 95 | $60.62 |
| 80358 | <1% | 27 | $60.50 | |
| 80348 | <1% | 27 | $60.50 | |
| 80365 | <1% | 27 | $60.50 | |
| 84450 | <1% | 30 | $60.36 | |
| 82950 | <1% | 12 | $57.00 | |
| 84100 | <1% | 26 | $56.88 | |
| 80329 | <1% | 32 | $54.00 | |
| 82043 | <1% | 12 | $51.91 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,671 | $51.07 |
| 83615 | <1% | 14 | $50.25 | |
| 82040 | <1% | 28 | $49.58 | |
| 80320 | <1% | 193 | $46.40 | |
| 82525 | <1% | 21 | $45.96 | |
| 82247 | <1% | 27 | $45.19 | |
| 84520 | <1% | 36 | $42.00 | |
| 84075 | <1% | 26 | $40.24 | |
| 84155 | <1% | 28 | $37.56 | |
| 84630 | <1% | 22 | $31.60 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 81 | $28.47 |
| 80359 | <1% | 14 | $25.20 | |
| 80337 | <1% | 14 | $25.20 | |
| 80326 | <1% | 14 | $25.20 | |
| 80364 | <1% | 14 | $25.20 | |
| 80347 | <1% | 14 | $25.20 | |
| 82805 | <1% | 27 | $24.13 | |
| 80306 | <1% | 37 | $16.19 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 16 | $13.76 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 13 | $7.00 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 13 | $6.02 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 77 | $4.12 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 194 | $2.78 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 14 | $0.21 |
| C1727 | Catheter, balloon tissue dissector, non-vascular (insertable) | 0% | 185 | $0.00 |
| 96127 | 0% | 359 | $0.00 | |
| 81000 | 0% | 44 | $0.00 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 0% | 36 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 12 | $0.00 |
| 80179 | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPICKREIGN, ADELE (CREDENTIALING COORDINATOR)
| Provider | Location | Paid |
|---|---|---|
| Adirondack Medical Center | Saranac Lake, NY | $708K |
| Adirondack Medical Center | Saranac Lake, NY | $23K |
| Adirondack Medical Center | Lake Placid, NY | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.